Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Microport Scientific Corp. (OTC: MCRPF).

Full DD Report for MCRPF

You must become a subscriber to view this report.

Recent News from (OTC: MCRPF)

Firehawk Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet
SHANGHAI , Sept. 4, 2018 /PRNewswire/ -- MicroPort Scientific Corporation ("MicroPort®", HK:0853) announced today that the clinical trial results for its Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®") which conducted a multi-center, randomized c...
Source: PR Newswire
Date: September, 03 2018 20:45
Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet
Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet Canada NewsWire SHANGHAI, Sept. 3, 2018 SHANGHAI , Sept. 3, 2018 /CNW/ -- MicroPort Scientific Corporation ("MicroP...
Source: Canada Newswire
Date: September, 03 2018 19:13
Microport Scientific Corp. 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Microport Scientific Corp. in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: March, 28 2018 13:28
Week In Review: China Renaissance Sets $7 Billion Goal For New VC/PE Funds, Including Biotech/Healthcare
Deals and Financings China Renaissance, a Beijing investment bank and VC/PE investor, plans to expand its investment funds operations, climbing from $3 billion assets under management currently to $10 billion over the next three years. At the moment, the company runs two funds: Huaxing G...
Source: SeekingAlpha
Date: November, 26 2017 10:52


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MCRPF.

About Microport Scientific Corp. (OTC: MCRPF)

Logo for Microport Scientific Corp. (OTC: MCRPF)

MicroPort is making the world a better place one patient at a time. In fact, for every seconds that pass, on average, one patient somewhere in the world has life saving, or quality of life improving medical intervention, using MicroPort products. Our company is all about improving human life through the practical application of innovative science. And our aim is to continually develop leading technologies and products for physicians, with life saving solutions and treatments for patients. We are a young company with an ambition to establish MicroPort as a globally recognised brand name. Yet as the business grows, we strive to retain our unique entrepreneurial spirit. We continue to demonstrate entrepreneurial achievement and innovation coupled with our commitment to improving the social wellbeing. We work in close cooperation with recognized international physicians and scientists worldwide, to develop a range of products that meet the highest quality and clinical standards. We develop, and produce an ever diversifying portfolio of products cover a wide range of business segments including Cardiovascular Devices, Orthopedic Devices, Diabetes Care and Endocrinal Management, Electrophysiological Devices, Endovascular Devices, Neurovascular Devices, Surgical Management and others. We are dedicated to make a patient oriented global enterprise focusing on minimally invasive and other emerging medical technologies. Our products touch the lives of many people every day and we take this important responsibility very seriously. We are proud that MicroPort products will always achieve the highest standards of quality and ensure improved health for the patient. We know our products offer hope and relief to many people around the world, and every one of our employees takes personal responsibility to achieve our vision. Today our products are used to save lives and improve patient health in hospitals throughout China and we export our products to regions all over the world, including America and Europe. Our company has a large and growing intellectual property portfolio and the strongest research and development team in China s medical device sector. The applied expertise of our R amp D team ensures our latest products are always innovative, as we strive to provide state of the art medical technologies and deliver the next generation of medical devices and treatments for chronic ailments. Central to this innovative approach is the inspiration provided by nature and our appreciation for the beauty of human biology. And it is our commercial achievements which enable us to give something back to the society which makes our success possible. Our commitment to social engagement and responsibility is an important aspect of our company culture and philosophy. MicroPort works diligently to build strong relationships with all our international partners and all our stakeholders, because as a Corporation, we think our community is an essential part of our business, and we strive to help in the best ways we can.


Contact Information



Current Management

  • Dr. Zhaohua Chang / CEO

Current Share Structure

  • Market Cap: $1,240,659,200 - 03/13/2018
  • Issue and Outstanding: 1,409,840,000 - 12/31/2013


Daily Technical Chart for (OTC: MCRPF)

Daily Technical Chart for (OTC: MCRPF)

Stay tuned for daily updates and more on (OTC: MCRPF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: MCRPF)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MCRPF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MCRPF and does not buy, sell, or trade any shares of MCRPF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: